Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation

British Journal of Cancer

Volumn 97, Issue 2, 2007, Pages 260-266

  Kawanishi, H ^a   Takahashi, T ^a   Ito, M ^a   Matsui, Y ^a   Watanabe, J ^a   Ito, N ^a   Kamoto, T ^a   Kadowaki, T ^a,b   Tsujimoto, G ^a   Imoto, I ^c,d   Inazawa, J ^c,d,e   Nishiyama, H ^a   Ogawa, O ^a  

^a KYOTO UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone   (Japan)

Author keywords

Array CGH; Genetic alterations; Multifocal low grade urothelial cancer

Indexed keywords

DNA MINISATELLITE; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ARTICLE; BLADDER CANCER; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME 17P; CHROMOSOME 2Q; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CLADISTICS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; KIDNEY PELVIS CANCER; LINEAR SYSTEM; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; URETER CANCER; UROGENITAL TRACT CANCER;

CHROMOSOMES, HUMAN; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; HUMANS; MUTAGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 34447343152     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603850     Document Type: Article

References (31)

1. Almadori G, Bussu F, Cadoni G, Galli J, Rigante M, Artuso A, Maurizi M (2004) Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur J Cancer 40: 2383-2388
2. Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B, Bralet MP, Lefrere-Belda MA, Lahaye JB, Abbou CC, Bonaventure J, Zafrani ES, van der Kwast T, Thiery JP, Radvanyi F (2001) Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol 158: 1955-1959
3. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012-7022
4. Dalbagni G, Ren ZP, Herr H, Cordon-Cardo C, Reuter V (2001) Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Clin Cancer Res 7: 2797-2801
5. Habuchi T (2005) Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 12: 709-716
6. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O (1993) Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342: 1087-1088
7. Hittelman WN (2001) Genetic instability in epithelial tissues at risk for cancer. Ann NY Acad Sci 952: 1-12
8. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA (2004) High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23: 2250-2263
9. Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA (2005) FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24: 5218-5225
10. Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, Cocco A, Cheng L (2005) Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 11: 6512-6519
11. Knowles MA (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27: 361-373
12. Koed K, Wiuf C, Christensen LL, Wikman FP, Zieger K, Moller K, von der Maase H, Orntoft TF (2005) High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Res 65: 34-45
13. Li M, Cannizzaro LA (1999) Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract. Hum Pathol 30: 1197-1200
14. Louhelainen J, Wijkstrom H, Hemminki K (2000) Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int J Cancer 87: 522-527
15. Oosterlinck W, Solsona E, Akaza H, Busch C, Goebell PJ, Malmstrom PU, Ozen H, Sved P (2005) Low-grade Ta (noninvasive) urothelial carcinoma of the bladder. Urology 66: 75-89
16. Paiss T, Wohr G, Hautmann RE, Mattfeldt T, Muller M, Haeussler J, Vogel W (2002) Some tumors of the bladder are polyclonal in origin. J Urol 167: 718-723
17. Primdahl H, Wikman FP, von der Maase H, Zhou XG, Wolf H, Orntoft TF (2002) Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J Natl Cancer Inst 94: 216-223
18. Shelley Hwang E, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100: 2562-2572
19. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin bladder cancer. N Engl J Med 326: 737-740
20. Simon R, Eltze E, Schafer KL, Burger H, Semjonow A, Hertle L, Dockhorn-Dworniczak B, Terpe HJ, Bocker W (2001) Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61: 355-362
21. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, Inazawa J (2004) Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64: 3741-3747
22. Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J (2005) ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene 24: 8051-8060
23. Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J (2006) Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. Oncogene 25: 6554-6562
24. Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi T, Yoshida O (1998) Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 58: 5835-5841
25. Tanami H, Tsuda H, Okabe S, Iwai T, Sugihara K, Imoto I, Inazawa J (2005) Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab Invest 85: 1118-1129
26. van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC (2001) The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 61: 1265-1268
27. van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC (2000) Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 9: 2973-2980
28. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM (2003) Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: 2872-2880
29. Wa CV, DeVries S, Chen YY, Waldman FM, Hwang ES (2005) Clinical application of array-based genomic hybridization to define the relationship between multiple synchronous tumors. Mod Pathol 18: 591-597
30. Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5: 713-725
31. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 59: 4658-4661